CareCloud (CCLD)
(Delayed Data from NSDQ)
$1.91 USD
-0.15 (-7.28%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $1.95 +0.04 (2.09%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CCLD 1.91 -0.15(-7.28%)
Will CCLD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CCLD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CCLD
Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?
Are Medical Stocks Lagging Annexon (ANNX) This Year?
CCLD: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Zacks Analyst Blog Highlights Byrna Technologies, CareCloud, American Superconductor, Alphabet and NVIDIA
5 Top Tech Stocks to Win Big With Nasdaq on a Roll
Is CareCloud (CCLD) Stock Outpacing Its Medical Peers This Year?
Other News for CCLD
CareCloud To Announce Second-Quarter 2024 Results on August 13, 2024
Voting on CareCloud?s Series A Proxy Continues with 82% of Early Proxies Favoring the Proposal
CareCloud announces 82% of early proxies favor proposal
Voting on CareCloud?s Series A Proxy Reveals an Encouraging Trend
CareCloud says Series A proxy reveals 'encouraging trend'